Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 Booster”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05812586
What this trial is testing

Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

Who this might be right for
COVID-19
D'Or Institute for Research and Education 760
Not applicableStudy completedNCT05392075
What this trial is testing

COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose

Who this might be right for
COVID-19 PneumoniaCOVID-19
Methodist Health System 100
Not applicableStudy completedNCT05158855
What this trial is testing

Oral Neutralizing Antibody Booster for Post-vaccinated People With COVID19 Vaccine

Who this might be right for
COVID-19 Pandemic
DreamTec Research Limited 16
Early research (Phase 1)WithdrawnNCT05430958
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 for COVID19 in Healthy Volunteers

Who this might be right for
Coronavirus Infection
Inovio Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT05132855
What this trial is testing

The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 Vaccine

Who this might be right for
COVID-19Breakthrough Infection
Chang Gung Memorial Hospital 340
Not applicableUnknownNCT05493917
What this trial is testing

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19Vaccine Reaction
Huashan Hospital 2,000
Post-approval studies (Phase 4)UnknownNCT05855408
What this trial is testing

Effectiveness of a Second COVID-19 Vaccine Booster in Chinese Adults

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 10,000
Early research (Phase 1)Looking for participantsNCT07536308
What this trial is testing

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT05137236
What this trial is testing

Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 540
Large-scale testing (Phase 3)Study completedNCT04762680
What this trial is testing

Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and Older

Who this might be right for
COVID-19
Sanofi Pasteur, a Sanofi Company 3,159
Testing effectiveness (Phase 2)WithdrawnNCT05602961
What this trial is testing

A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster

Who this might be right for
COVID-19
GreenLight Biosciences, Inc.
Large-scale testing (Phase 3)WithdrawnNCT05926440
What this trial is testing

Immunogenicity and Safety Study of SCB-2023 Vaccine as a Booster in Adults

Who this might be right for
COVID-19
Clover Biopharmaceuticals AUS Pty
Testing effectiveness (Phase 2)UnknownNCT05490108
What this trial is testing

Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Shanghai Zerun Biotechnology Co.,Ltd 60
Not applicableStudy completedNCT06156215
What this trial is testing

PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED

Who this might be right for
COVID-19
University of California, San Francisco 919
Post-approval studies (Phase 4)Temporarily pausedNCT05165732
What this trial is testing

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 480
Not applicableUnknownNCT05204602
What this trial is testing

Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases

Who this might be right for
COVID-19Vaccine ReactionLiver Diseases
Huashan Hospital 1,000
Early research (Phase 1)Study completedNCT05685953
What this trial is testing

A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine

Who this might be right for
COVID-19 Respiratory InfectionCOVID-19 Vaccine Adverse Reaction
Matti Sällberg 16
Not applicableStudy completedNCT05373459
What this trial is testing

Effect of a Third COVID-19 Booster Among Health Care Workers

Who this might be right for
COVID-19 Vaccines
Hong Kong Sanatorium & Hospital 3,167
Testing effectiveness (Phase 2)UnknownNCT05911048
What this trial is testing

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 3,100
Testing effectiveness (Phase 2)Study completedNCT05593042
What this trial is testing

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Who this might be right for
COVID-19Vaccines
Pontificia Universidad Catolica de Chile 551
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation